First cannabis-based medicine approved by FDA arrives in the U.S.

For the first time, a marijuana-based medicine approved by federal regulators is available for prescription in the United States.

The medicine, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological disorder, according to a news release.

“Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures,” said Justin Gover, chief executive officer of GW Pharmaceuticals, the United Kingdom-based company that developed the drug, in a statement.

Read the rest of this story on DenverPost.com.

Facebook Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Skip to toolbar